GLP-1 Revolution: From diabetes to weight loss and beyond.

Join Dr. Ted Feldman, Chief Medical Officer at Rightway, and Kristin Devlin, Senior VP of Pharmacy, as they unpack GLP-1 drugs — a groundbreaking class of medicines reshaping treatment for diabetes, obesity, and cardiometabolic disease.

In this episode, they explain:

  • How GLP-1s work and why they’re generating so much attention.
  • Who may benefit most from these therapies.
  • Practical considerations like safety, access, and adherence.
  • How Rightway supports members with benefit navigation, manufacturer programs, and cost-saving strategies.

Listen to the podcast.

SHARE